The authorization permits the company to use the following claim for the approved products: "Using ZYN instead of cigarettes puts you at a lower risk of mouth cancer, heart disease, lung cancer, stroke, emphysema, and chronic bronchitis." For the travel retail tobacco category, the decision represents another regulatory milestone for smoke-free alternatives, with PMI expanding the number of products in its portfolio that have received FDA modified-risk authorization
Then, at 5 years removed from smoking or tobacco use, you would qualify for super preferred, premier, or preferred plus
For more on this story and other local news, subscribe to The Valdosta Daily Times e-Edition, or our print edition.
Most people switching from regular daily smoking find Level 2 to 3 (6 to 9mg) the right landing zone